Research Article
Serum Biomarkers for Chronic Renal Failure Screening and Mechanistic Understanding: A Global LC-MS-Based Metabolomics Research
Table 4
Potential renal failure metabolites.
| No | Metabolites | Level in patients | AUC |
| 1 | Creatinine | ↑ | 0.997 | 2 | 1-methylhypoxanthine | ↑ | 1 | 3 | Beta-carboline | ↑ | 0.964 | 4 | Arabinofuranobiose | ↑ | 1 | 5 | Valdecoxib | ↓ | 1 | 6 | Glycerol tripropanoate | ↑ | 0.982 | 7 | 4-Guanidinobutanoic acid | ↑ | 1 | 8 | Kynurenic acid | ↑ | 1 | 9 | Alcophosphamide | ↓ | 1 | 10 | 1-(Beta-D-ribofuranosyl)-1, 4-dihdronicotinamide | ↑ | 1 | 11 | Thelephoric acid | ↓ | 1 | 12 | 5′-Methylthioadenosine | ↑ | 1 | 13 | 3-Methylglutarylcarnitine | ↑ | 1 | 14 | Formiminoglutamic acid | ↑ | 0.994 | 15 | Solacauline | ↑ | 1 | 16 | PC (20 : 5 (5Z, 8Z, 11Z, 17Z)/(20 : 5 (5Z, 8Z, 11Z, 17Z)) | ↑ | 1 | 17 | Serylalanine | ↓ | 1 | 18 | 5, 6-Dihydrouridine | ↑ | 1 | 19 | L-Beta-aspartyl-L-threonine | ↓ | 1 | 20 | Isoleucyl-alanine | ↑ | 0.999 | 21 | Beta-solamarine | ↑ | 1 | 22 | Presqualene diphosphate | ↑ | 1 | | Lycoperoside D | ↑ | 1 | 24 | 2-O-(6-Phospho-alpha-mannosyl)-D-glycerate | ↓ | 1 | 25 | 2, 8-Di-O-methylellagic acid | ↓ | 1 | 26 | Perlolyrine | ↑ | 0.993 | 27 | 3, 3′, 4′, 5, 6, 7, 8-Heptahydroxyflavone | ↓ | 1 | 28 | Threoninyl-aspartate | ↓ | 1 | 29 | Paraquat dichloride | ↓ | 1 | 30 | Azelaic acid | ↑ | 1 | 31 | (10E, 12Z)-9-HODE | ↑ | 1 | 32 | N-acetylglutamine | ↑ | 1 | 33 | 4-acetamidobutanoic acid | ↑ | 1 | 34 | N-acetyl-L-alanine | ↑ | 0.997 | 35 | Mycophenolic acid | ↑ | 1 | 36 | Formylanthranilic acid | ↑ | 1 | 37 | Trehalose | ↑ | 1 | 38 | Prostaglandin F3a | ↑ | 1 | 39 | Thymine | ↑ | 0.996 | 40 | Kynurenic acid | ↑ | 1 | 41 | Tiglic acid | ↑ | 0.975 | 42 | N-acetylserine | ↑ | 1 | 43 | Glutamyltheronine | ↓ | 1 | 44 | 3-methoxy-4-hydroxyphenylethyleneglycol sulfate | ↑ | 0.999 |
|
|
presents the metabolites identified in kidney disease had been reported. |